NCT06067815 is a clinical trial in Mitral Stenosis, sponsored by Assiut University.

Who is sponsoring NCT06067815?

NCT06067815 is sponsored by Assiut University.

What condition does NCT06067815 study?

NCT06067815 studies Mitral Stenosis.

Is NCT06067815 still recruiting?

NCT06067815 is currently status unknown. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT06067815

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Right Ventricular Function in Patients With Severe Mitral Stenosis Before and After Balloon Mitral Valvuloplasty

Status unknown Last updated 5 October 2023

What this trial tests

trial in Mitral Stenosis in 30 participants. Status unknown.

Timeline

1 October 2023

Primary endpoint
1 October 2024

1 November 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 October 2023
Primary completion	1 October 2024
Estimated completion	1 November 2024

Conditions studied

Mitral Stenosis — all drugs for Mitral Stenosis →

Sponsor

Assiut University

Who can join

Adults 16 to 70, any sex, with Mitral Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To detect short-term impacts of successful balloon mitral valvuloplasty on right ventricular function

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mitral Stenosis

Currently open trials in the same condition.

NCT07175532 — Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy · recruiting
NCT06377449 — Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients · NA · recruiting
NCT05625607 — Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry · recruiting
NCT04045093 — Dabigatran for Mitral Stenosis Atrial Fibrillation · Phase 4 · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06067815 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06067815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing